Skip to main content
. 2017 Dec 30;9(6):6814–6829. doi: 10.18632/oncotarget.23784

Table 3. TLR2 and/or AR stimuli induce Ki-67 mRNA expression in OSCC cells by 24 hrs.

stimuli KER PCI13 CAL27 UMSCC19
none 1.00 ± 0.02 1.00 ± 0.03 1.00 ± 0.05 1.00 ± 0.02
TLR2/1+2/6 1.15 ± 0.03* 3.02 ± 0.63*** 1.52 ± 0.04**** 1.11 ± 0.02**
AR 1.08 ± 0.07 2.03 ± 0.35* 1.45 ± 0.003**** 1.03 ± 0.04
TLR2/1+2/6+AR 0.94 ± 0.08 1.49 ± 0.27* 2.11 ± 0.05**** 1.01 ± 0.04
EGF 1.52 ± 0.04**** 3.14 ± 0.78*** 1.42 ± 0.05**** 0.70 ± 0.02**

Fold change relative to unstimulated cells, ± SD.

Bold = significant; *p < .05; **p < .01; ***p < .001; ****p < .0001.

OSCC cells Cal27, PCI13 and UMSCC19, and keratinocytes hTERT HAK Clone 41 were incubated for 2, 4, and 24 hrs with EGF, or with one or more of the TLR2/1, 2/6 ligands and AR agonist NECA, as indicated in Materials and Methods. Cellular mRNA was evaluated for Ki-67 and GAPDH expression by qRT-PCR, in triplicate. Fold changes relative to unstimulated cells ± SD are shown. Data were analyzed using one way ANOVA, including Tukey-Kramer test for multiple comparisons.